相关实验视频

Updated: Jan 18, 2026

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

在2型糖尿病模型中使用人类iPSC衍生的血管修复细胞向糖尿病视网膜病变

Sergio Li Calzi¹, Dibyendu Chakraborty¹, Ping Hu¹

¹Department of Ophthalmology and Visual Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL 35294, USA.

|September 13, 2025

概括

人类诱导多能干细胞 (hiPSC) 衍生的CD34+细胞和内皮细胞殖民地形成细胞 (iPSC-ECFCs) 显示出糖尿病视网膜病变 (DR) 的治疗潜力. 组合疗法在视网膜厚度和分子通路方面显示出特定的益处.

科学领域:

再生医学是一种再生医学.
眼科医生眼科眼科
干细胞生物学干细胞生物学

背景情况:

糖尿病视网膜病变 (DR) 是导致视力丧失的主要原因,其特点是视网膜血管损伤.
目前对DR的治疗有局限性,不能完全恢复视网膜功能或结构.
人类诱导的多能干细胞 (hiPSCs) 为血管修复疗法提供了一个有前途的来源.

研究的目的:

评估hiPSC衍生的CD34+细胞和iPSC-ECFCs单独或组合的治疗疗效,用于DR的小鼠模型中的血管修复.
评估基于hiPSC的细胞移植后视网膜的功能和结构恢复.
研究治疗效果背后的细胞融合和分子机制.

主要方法:

将hiPSC-CD34+细胞或iPSC-ECFCs (单独或组合) 静脉内注射给免疫抑制的2型糖尿病 (db/db) 小鼠.
使用电网膜学 (ERG) 进行功能评估,通过光学连贯性断层学 (OCT) 进行结构评估,注射后一个月.
免疫组织化学 (IHC) 用于细胞定位和逆相蛋白阵列 (RPPA) 用于蛋白质组分析.

主要成果:

无论是hiPSC-CD34+细胞还是iPSC-ECFCs,都显著改善了视网膜功能 (ERG).
由hiPSC-CD34+细胞和组合疗法恢复了视网膜厚度,但仅由iPSC-ECFCs无法恢复.
hiPSC-CD34+细胞定位在周血管上,而iPSC-ECFCs集成到视网膜血管结构中;RPPA揭示了组合特异性的分子通路调节.

结论:

由hiPSC衍生的CD34+细胞和iPSC-ECFCs显示了DR的治疗潜力,无论是单独的还是组合的.
组合疗法在恢复视网膜厚度和调节特定分子通路方面表现出独特的好处.
这些发现支持开发基于hiPSC的细胞疗法,用于像DR这样的视网膜血管疾病.

关键词:

CD34细胞是CD34细胞.这些细胞是KNA细胞.糖尿病视网膜病变糖尿病视网膜病变内皮细胞是形成殖民地的细胞.可以诱导的多能干细胞干细胞.血管修复血管修复

更多相关视频

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Directed Induction of Retinal Organoids from Human Pluripotent Stem Cells

Published on: April 21, 2021

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...